Picture of Y-mAbs Therapeutics logo

YMAB — Y-mAbs Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapHigh Flyer

Brief: Y-Mabs Reaches Agreement with EMA On The Pediatric Investigation Plan For Naxitamab

Feb 2 (Reuters) - Y-mAbs Therapeutics Inc  YMAB.O :
    * Y-MABS AND THE EUROPEAN MEDICINES AGENCY REACH AGREEMENT
ON THE
PEDIATRIC INVESTIGATION PLAN FOR NAXITAMAB
    * Y-MABS AND EUROPEAN MEDICINES AGENCY REACH AGREEMENT ON
PEDIATRIC INVESTIGATION PLAN FOR NAXITAMAB
    * Y-MABS THERAPEUTICS INC -  DECISION FOLLOWS A POSITIVE
OPINION
FROM EMA'S PEDIATRIC COMMITTEE

Source text for Eikon:  ID:nGNX6b2D6g 
Further company coverage:  YMAB.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Y-mAbs Therapeutics

See all news